These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 25271285)

  • 61. YejM Controls LpxC Levels by Regulating Protease Activity of the FtsH/YciM Complex of Escherichia coli.
    Nguyen D; Kelly K; Qiu N; Misra R
    J Bacteriol; 2020 Aug; 202(18):. PubMed ID: 32540932
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Syntheses, structures and antibiotic activities of LpxC inhibitors based on the diacetylene scaffold.
    Liang X; Lee CJ; Chen X; Chung HS; Zeng D; Raetz CR; Li Y; Zhou P; Toone EJ
    Bioorg Med Chem; 2011 Jan; 19(2):852-60. PubMed ID: 21194954
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An Essential Membrane Protein Modulates the Proteolysis of LpxC to Control Lipopolysaccharide Synthesis in Escherichia coli.
    Fivenson EM; Bernhardt TG
    mBio; 2020 May; 11(3):. PubMed ID: 32430473
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment of human challenge and MDR strains of Neisseria gonorrhoeae with LpxC inhibitors.
    John CM; Feng D; Jarvis GA
    J Antimicrob Chemother; 2018 Aug; 73(8):2064-2071. PubMed ID: 29726994
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular Safety.
    Cohen F; Aggen JB; Andrews LD; Assar Z; Boggs J; Choi T; Dozzo P; Easterday AN; Haglund CM; Hildebrandt DJ; Holt MC; Joly K; Jubb A; Kamal Z; Kane TR; Konradi AW; Krause KM; Linsell MS; Machajewski TD; Miroshnikova O; Moser HE; Nieto V; Phan T; Plato C; Serio AW; Seroogy J; Shakhmin A; Stein AJ; Sun AD; Sviridov S; Wang Z; Wlasichuk K; Yang W; Zhou X; Zhu H; Cirz RT
    ChemMedChem; 2019 Aug; 14(16):1560-1572. PubMed ID: 31283109
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Structure of the bacterial deacetylase LpxC bound to the nucleotide reaction product reveals mechanisms of oxyanion stabilization and proton transfer.
    Clayton GM; Klein DJ; Rickert KW; Patel SB; Kornienko M; Zugay-Murphy J; Reid JC; Tummala S; Sharma S; Singh SB; Miesel L; Lumb KJ; Soisson SM
    J Biol Chem; 2013 Nov; 288(47):34073-34080. PubMed ID: 24108127
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
    Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C
    J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibition of Fosfomycin Resistance Protein FosA by Phosphonoformate (Foscarnet) in Multidrug-Resistant Gram-Negative Pathogens.
    Ito R; Tomich AD; McElheny CL; Mettus RT; Sluis-Cremer N; Doi Y
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993329
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Application of Virtual Screening to the Identification of New LpxC Inhibitor Chemotypes, Oxazolidinone and Isoxazoline.
    Lee PS; Lapointe G; Madera AM; Simmons RL; Xu W; Yifru A; Tjandra M; Karur S; Rico A; Thompson K; Bojkovic J; Xie L; Uehara K; Liu A; Shu W; Bellamacina C; McKenney D; Morris L; Tonn GR; Osborne C; Benton BM; McDowell L; Fu J; Sweeney ZK
    J Med Chem; 2018 Oct; 61(20):9360-9370. PubMed ID: 30226381
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.
    Moffatt JH; Harper M; Harrison P; Hale JD; Vinogradov E; Seemann T; Henry R; Crane B; St Michael F; Cox AD; Adler B; Nation RL; Li J; Boyce JD
    Antimicrob Agents Chemother; 2010 Dec; 54(12):4971-7. PubMed ID: 20855724
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Predictive Rules of Efflux Inhibition and Avoidance in Pseudomonas aeruginosa.
    Mehla J; Malloci G; Mansbach R; López CA; Tsivkovski R; Haynes K; Leus IV; Grindstaff SB; Cascella RH; D'Cunha N; Herndon L; Hengartner NW; Margiotta E; Atzori A; Vargiu AV; Manrique PD; Walker JK; Lomovskaya O; Ruggerone P; Gnanakaran S; Rybenkov VV; Zgurskaya HI
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468691
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mechanistic inferences from the binding of ligands to LpxC, a metal-dependent deacetylase.
    Gennadios HA; Whittington DA; Li X; Fierke CA; Christianson DW
    Biochemistry; 2006 Jul; 45(26):7940-8. PubMed ID: 16800620
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii.
    García-Quintanilla M; Caro-Vega JM; Pulido MR; Moreno-Martínez P; Pachón J; McConnell MJ
    Antimicrob Agents Chemother; 2016 Aug; 60(8):5076-9. PubMed ID: 27270288
    [TBL] [Abstract][Full Text] [Related]  

  • 74. LpxC (UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase) inhibitors: A long path explored for potent drug design.
    Kumar Pal S; Kumar S
    Int J Biol Macromol; 2023 Apr; 234():122960. PubMed ID: 36565833
    [TBL] [Abstract][Full Text] [Related]  

  • 75. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
    Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
    Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Uridine-based inhibitors as new leads for antibiotics targeting Escherichia coli LpxC.
    Barb AW; Leavy TM; Robins LI; Guan Z; Six DA; Zhou P; Hangauer MJ; Bertozzi CR; Raetz CR
    Biochemistry; 2009 Apr; 48(14):3068-77. PubMed ID: 19256534
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Design, organocatalytic synthesis, and bioactivity evaluation of enantiopure fluorinated LpxC inhibitors.
    Rodríguez-Alvarado M; Russo R; Connell ND; Brenner-Moyer SE
    Org Biomol Chem; 2020 Aug; 18(30):5867-5878. PubMed ID: 32671374
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Potent, novel in vitro inhibitors of the Pseudomonas aeruginosa deacetylase LpxC.
    Kline T; Andersen NH; Harwood EA; Bowman J; Malanda A; Endsley S; Erwin AL; Doyle M; Fong S; Harris AL; Mendelsohn B; Mdluli K; Raetz CR; Stover CK; Witte PR; Yabannavar A; Zhu S
    J Med Chem; 2002 Jul; 45(14):3112-29. PubMed ID: 12086497
    [TBL] [Abstract][Full Text] [Related]  

  • 79. yciM is an essential gene required for regulation of lipopolysaccharide synthesis in Escherichia coli.
    Mahalakshmi S; Sunayana MR; SaiSree L; Reddy M
    Mol Microbiol; 2014 Jan; 91(1):145-57. PubMed ID: 24266962
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.
    Krishnamoorthy G; Leus IV; Weeks JW; Wolloscheck D; Rybenkov VV; Zgurskaya HI
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.